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A B S T R A C T   
Background: Chaiqin chengqi decoction (CQCQD) is a Chinese herbal formula derived from dachengqi decoc-
tion. CQCQD has been used for the management of acute pancreatitis (AP) in the West China Hospital for more 
than 30 years. Although CQCQD has a well-established clinical efficacy, little is known about its bioactive 
ingredients, how they interact with different therapeutic targets and the pathways to produce anti-inflammatory 
effects. 
Purpose: Toll-like receptor 4 (TLR4) and the nucleotide-binding oligomerization domain-like receptor family 
pyrin domain containing 3 (NLRP3) inflammasome-mediated pro-inflammatory signaling pathways, play a 
central role in AP in determining the extent of pancreatic injury and systemic inflammation. In this study, we 
screened the bioactive ingredients using a pharmacological sub-network analysis based on the TLR4/NLRP3 
signaling pathways followed by experimental validation. 
Methods: The main CQCQD bioactive compounds were identified by UPLC-QTOF/MS. The TLR4/NLRP3 targets 
in AP for CQCQD active ingredients were confirmed through a pharmacological sub-network analysis. Mice 
received 7 intraperitoneal injections of cerulein (50 μg/kg; hourly) to induce AP (CER-AP), while oral gavage of 
CQCQD (5, 10, 15 and 20 g/kg; 3 doses, 2 hourly) was commenced at the 3rd injection of cerulein. 
Histopathology and biochemical indices were used for assessing AP severity, while polymerase chain reaction, 
Western blot and immunohistochemistry analyses were used to study the mechanisms. Identified active CQCQD 
compounds were further validated in freshly isolated mouse pancreatic acinar cells and cultured RAW264.7 
https://doi.org/10.1016/j.phymed.2020.153328 
Received 4 March 2020; Received in revised form 8 June 2020; Accepted 22 June 2020    
Abbreviations: AP, acute pancreatitis; BA, baicalin; CCK, cholecystokinin; CER, cerulein; CH, chrysin; CI, combination index; CQCQD, chaiqin chengqi decoction; 
DAMPs, damage-associated molecular pattern molecules; DCQD, dachengqi decoction; DMEM, Dulbecco's modified Eagle medium; EM, emodin; ETCM, Encyclopedia 
of Traditional Chinese Medicine; IL-6, interleukin-6; IL-1β, interleukin-1β; KEGG, Kyoto Encyclopedia of Genes and Genomes; LPS, lipopolysaccharide; MPO, 
myeloperoxidase; MyD88, myeloid differentiation primary response 88; NF-κB, nuclear factor- kappaB; NLRP3, NOD-like receptor family pyrin domain containing 3; 
PI, propidium iodide; PPI, Protein-Protein Interaction; RH, rhein; RT-qPCR, real-time quantitative polymerase chain reaction; SITICH, Search Tool for Interactions of 
Chemicals; TCM, traditional Chinse medicine; TLCS, taurolithocholic acid 3-sulfate disodium salt; TLR4, Toll-like receptor 4; TNF-α, tumor necrosis factor-alpha 
⁎ Corresponding authors: Sichuan Provincial Pancreatitis center and West China-Liverpool Biomedical Research center, West China Hospital of Sichuan University, 
5B Floor 2nd Building, Tianfu Life Science Park of Hi-Tech Industrial Development Zone, No. 88 Keyuan South Road, Chengdu 610041, China. 
E-mail addresses: dudan@wchscu.cn (D. Du), dr_wei_huang@scu.edu.cn (W. Huang), xiaqing@medmail.com.cn (Q. Xia). 
1 These authors contributed equally as co-first authors. 
Phytomedicine 79 (2020) 153328
0944-7113/ © 2020 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).
T
macrophages. 
Results: The main compounds from CQCQD belonged to flavonoids, iridoids, phenols, lignans, anthraquinones 
and corresponding glycosides. The sub-network analysis revealed that emodin, rhein, baicalin and chrysin were 
the compounds most relevant for directly regulating the TLR4/NLRP3-related proteins TLR4, RelA, NF-κB and 
TNF-α. In vivo, CQCQD attenuated the pancreatic injury and systemic inflammation of CER-AP and was asso-
ciated with reduced expression of TLR4/NLRP3-related mRNAs and proteins. Emodin, rhein, baicalin and 
chrysin significantly diminished pancreatic acinar cell necrosis with varied effects on suppressing the expression 
of TLR4/NLRP3-related mRNAs. Emodin, rhein and chrysin also decreased nitric oxide production in macro-
phages and their combination had synergistic effects on alleviating cell death as well as expression of TLR4/ 
NLRP3-related proteins. 
Conclusions: CQCQD attenuated the severity of AP at least in part by inhibiting the TLR4/NLRP3 pro-in-
flammatory pathways. Its active ingredients, emodin, baicalin, rhein and chrysin contributed to these beneficial 
effects.   
Introduction 
Acute pancreatitis (AP) is an inflammatory digestive system disease 
with growing prevalence. It currently has an estimated global incidence 
rate of 33 cases per 100,000 person-years (Xiao et al., 2016). Although 
gallstones and excess alcohol consumption have been recognized as two 
leading causes of AP globally (Forsmark Ch et al., 2017), recent studies 
revealed that hypertriglyceridemia-associated AP is becoming the pre-
dominant etiology of AP cases in China (Ding et al., 2019;  
Mukherjee et al., 2019; Shi et al., 2020; Zhang et al., 2019c). 
AP cases with local complications (i.e. acute necrotic and peripan-
creatic fluid collections) and persistent organ failure are defined as 
“moderately severe” or “severe” (Banks et al., 2013; Crockett et al., 
2018). Due to an increased risk of developing sepsis, and needing in-
vasive interventions, patients in these groups typically require in-
tensive-care management (Schepers et al., 2019; Shi et al., 2020). The 
high morbidity and mortality rate associated with these patients results 
in significant socioeconomical burdens (Peery et al., 2019). Despite an 
intensive search of potential interventions, there remains no effective 
pharmacological treatment for managing these AP cases (Moggia et al., 
2017). 
Recent progress in translational research has deepened our under-
standing of the fundamental processes contributing to the initiation and 
aggravation of AP (Lee and Papachristou, 2019). Upon exposure to 
classic pancreatic toxins (i.e. bile acid), human pancreatic acinar cells 
release pro-inflammatory cytokines (interleukin [IL]-1β, IL-6 and tumor 
necrosis factor-alpha [TNF-α]), chemokines and chemokine receptors 
(Lugea et al., 2017) as well as damage-associated molecular pattern 
molecules (DAMPs; i.e. cell-free DNA, high mobility groupbox 1 and 
histones) (Hoque et al., 2011; Kang et al., 2014b; Liu et al., 2017;  
Merza et al., 2015) into extracellular milieu to initiate so-called sterile 
inflammation. Toll-like receptors (TLRs; TLR4/9) (Chen et al., 2014;  
Kang et al., 2014a; Vaz et al., 2013) and inflammasomes (Hoque et al., 
2012; Hoque and Mehal, 2015) are proteins that are essential to the 
sensing of DAMPs and signal transduction, respectively, and are both 
needed to completely activate the systemic inflammation cascade after 
AP onset. The “TLR4” and “nucleotide-binding oligomerization domain- 
like receptor (NLR) family pyrin domain containing 3 (NLRP3)” in-
flammasome are the most well studied inflammatorysignaling cassettes 
in experimental AP. TLR4 is expressed in pancreatic acinar cells 
(Gu et al., 2013), immune cells, epithelium of pancreatic duct and 
pancreatic microcirculation (Vaz et al., 2013). Genetic knockout of 
TLR4 (or its co-receptor CD14) (Sharif et al., 2009), TLR4 downstream 
signaling cytosolic protein myeloid differentiation primary response 88 
(MyD88) (Koike et al., 2012) and nuclear factor-kappaB (NF-κB) 
(Huang et al., 2013) or pharmacologic inhibition of TLR4 by lactate 
(Hoque et al., 2014) and TLR4 specific antagonist TAK242 (Awla et al., 
2011) can all significantly reduce the severity of experimental AP in 
mouse models. The NLRP3 inflammasome is expressed by innate im-
mune cells, stimulated pancreatic acinar cells and especially in 
macrophages (Hoque et al., 2012; Hoque and Mehal, 2015; 2011;  
Sendler et al., 2020). Genetic deletion or pharmacological antagonism 
of NLRP3 inflammasome elements (caspase-1, ASC, or NLRP3) also 
greatly diminished pancreatic injury and systemic inflammation in AP 
models (Hoque et al., 2011; Sendler et al., 2020). Since novel inhibitors 
are being developed for targeting TLR4 and NLRP3 inflammasome 
(Bhattacharyya et al., 2018; Coll et al., 2015), these strategies may hold 
substantial promise for treating human AP. 
In China, it is a common and well-established practice to use rhu-
barb-based Traditional Chinese Medicine (TCM) herbal formula such as 
dachengqi decoction (DCQD) for AP care. At our hospital, we have 
refined and successfully employed a DCQD-derived formula known as 
chaiqin chengqi decoction (CQCQD) to manage AP patients for over 30 
years (Liu et al., 2004). Systematic review (Wang et al., 2005) and 
meta-analyses (Lu et al., 2014) of observation studies and trials with 
small sample size have demonstrated the effectiveness of TCM in im-
proving AP's clinical outcomes, with higher quality randomized clinical 
trials planned for the near future. Existing work has shown that 
bioactive ingredients such as emodin, rhein, baicalin and honokiol in 
DCQD and CQCQD, can significantly reduce the severity of experi-
mental AP by suppressing pro-inflammatory mediators (Lu et al., 2017;  
Zhou et al., 2016). However, the exact action of individual ingredients 
responsible for the various pharmacological responses and the me-
chanism underlying the synergistic protective effects remain to be 
clarified. 
Since TLR4/NLRP3 pro-inflammatory pathways play a central role 
in determining the extent of pancreatic injury in AP, in this study we 
sought to: (1) screen CQCQD bioactive ingredients that had the main 
inhibitory effects on TLR4/NLRP3 pathways using a sub-network 
pharmacology analysis; (2) evaluate the efficacy of CQCQD on the se-
verity of experimental AP and its pro-inflammatory signaling pathways 
in vivo; (3) validate the effects of these bioactive compounds on pan-
creatic acinar cells and macrophages. 
Materials and methods 
Ethics and animals 
All animal experiments were approved by the Animal Ethics 
Committee of West China Hospital, Sichuan University (2017065A and 
2019170A). Male C57BL/6J mice (22–25 g) were purchased from 
Beijing Huafukang Bioscience Co., Ltd. (Beijing, China). Animals were 
maintained at 22  ±  2 °C with a 12 h light-dark cycle and ad libitum 
feeding of standard laboratory chow and water throughout the ex-
periment. 
Materials and reagents 
The detailed information of reagents, natural compound standards 
and quantitative reverse transcription polymerase chain reaction (RT- 
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qPCR) primer pairs are provided in the Supplementary materials and 
methods and Tables S1–2. 
Preparation of CQCQD 
The raw materia medica of CQCQD were purchased from Sichuan 
Hospital of Traditional Chinese Medicine (Chengdu, Sichuan, China). 
CQCQD formula consisted of Bupleurum marginatum Wall. ex DC, 
Scutellaria baicalensis Georgi, Rheum palmatum L., Sodium Sulfate, 
Magnolia officinalis Rehd. et Wils, Citrus aurantium L., 
Gardenia jasminoides Ellisand Artemisia capillaris Thunb. The detailed 
information of materia medica from CQCQD is provided in Table 1. All 
the dried herbs except Rheum palmatum L. and Sodium Sulfate were 
first soaked in 800 ml sterile filtered water for 30 min then boiled with 
1000 ml sterile filtered water for 30 min and reduced to a concentrated 
solution (~200 ml). The concentrated liquid was then removed from 
the dregs and stored separately. Another 1000 ml water was added to 
the dregs then boiled and reduced again as described above. In the last 
5 min of the boiling procedure, Rheum palmatum L. was supplemented, 
while Sodium Sulfate was mixed at the end of the procedure. The twice 
extracted solution was combined (~400 ml) and lyophilized into 
powder using an EYELA FDU-2110 lyophilizer (Tokyo Rikakikai Co., 
Ltd.; Tokyo, Japan) and stored at −20 °C. 
UPLC-QTOF/MS analysis of CQCQD and standards 
Lyophilized CQCQD extractions were dissolved in hot water and 
obtained as 0.5 mg/ml solution. Under optimized chromatography 
conditions, all ingredients were separated within 20 min. Solution for 
CQCQD and standards was analyzed on a UPLC HeClass coupled with a 
Waters SYNAPT G2-Si HDMS Q-TOF (Waters Corporation; Milford, MA, 
USA). Separation was performed on a BEH C18 column (2.1 × 100 mm, 
1.7 μm) at 40 °C. Gradient elution of 0.1% formic acid solution (A) and 
methanol (B) at a flow rate of 0.4 ml/min was employed as follows: 
0–1.0 min, 5%B; 1.0–5 min, 5–50%B; 5–12 min, 50–90% B; 12–15 min, 
90% B; 15–16 min, 90–5%B; 16–20 min, 5% B. The injection volume 
was 1 μl. The Q-TOF system was operated using an electrospray ion 
source in negative ion modes. The mass range was set at m/z 50–1200. 
The capillary voltage was 1.0 KV. The source temperature was 120 °C, 
and the desolvation temperature was 400 °C. Cone gas flow and deso-
lvation gas flow were 50 and 800 l/h, respectively. Data were acquired 
on MSE mode and analyzed using a UNIFI 1.9.2 software (Waters 
Corporation). 
Pharmacology sub-network construction and analysis 
Main pharmacology network (compounds-targets-pathways) con-
struction:  
(1) Major identified compounds from CQCQD and their corresponding 
149 targets were predicted using Search Tool for Interactions of 
Chemicals (SITICH; http://stitch.embl.de/) and Encyclopedia of 
Traditional Chinese Medicine (ETCM; http://www.nrc.ac.cn:9090/ 
ETCM/) databases, based on structural and functional similarities 
(Tanimoto > 0.8); 
(2) AP-associated 530 targets were identified from the following da-
tabase: OMIM (https://www.omim.org/), DisGeNET (http://www. 
disgenet.org), NCBI, etc.;  
(3) The Protein-Protein Interaction (PPI) network of con-targets (the 
overlapping targets from CQCQD major identified compounds and 
AP) was constructed based on STRING database (https://string-db. 
org/); then pathways enrichment analysis was conducted via Kyoto 
Encyclopedia of Genes and Genomes (KEGG) signaling based on 
con-targets. 
Sub-network establishment: 
(1) TLR4/NLRP3-related pathways (TLR, NF-κB and NLR) were se-
lected based on KEGG signaling pathways enrichment analysis; 
(2) Subsequently, targets related to TLR4/NLRP3 pathways were ob-
tained from PPI network of con-targets;  
(3) A sub-network of TLR4/NLRP3 pathways-targets-compounds was 
extracted from the main network. 
Induction of experimental AP and severity assessment 
Mice received seven intraperitoneal injections of a cholecystokinin 
(CCK) analog cerulein (50 μg/kg) at hourly intervals, while controls 
received injections of normal saline. In the treatment groups, oral ga-
vage of different doses of CQCQD (5, 10, 15 and 20 g/kg) begun at the 
3rd injection of cerulein, and were given 3 times at 2 hourly intervals. 
Animals were humanely culled at 12 h from the first injection of cer-
ulein/saline. Relevant organs were harvested via an abdominal midline 
incision for severity assessment. Pancreatic and lung histopathology 
assessment and detailed protocols for serum amylase, pancreatic trypsin 
and myeloperoxidase (MPO), lung MPO and serum IL-6 were as pre-
viously described (Huang et al., 2017). 
RT-qPCR, Western blot and immunohistochemistry 
Detailed protocols for these assays are demonstrated in 
Supplementary materials and methods. 
Acinar cell isolation, RAW264.7 cell culture and cell injury assessment 
Pancreatic acinar cells were freshly isolated using a collagenase IV 
digestion procedure as we previously described (Huang et al., 2014). 
Cells were maintained in HEPES buffer (pH 7.3; in mM: HEPES 10, D- 
glucose 10, NaCl 140, KCl 4.7, MgCl2 1.13 and CaCl2 1.2). Cells were 
pre-treated with compounds (12.5, 25 and 50 μM) for 30 min at de-
signed concentrations, followed by co-incubation with CCK (500 nM) 
for 2 h, taurolithocholic acid 3-sulfate disodium salt (TLCS; 500 μM) for 
30 min, or lipopolysaccharide (LPS; 1 μg/ml) for 30 min with gentle 
shake at 50 rpm under room temperature; control groups received 
HEPES buffer incubation. Then cells were viewed by epi‑fluorescence 
microscopy ZEISS AX10 imager A2/AX10 cam HRC (Jena GmbH, 
Table 1 
The Ingredients list of CQCQD.       
Ingredients English name Latin name Plant name Weight (g)  
Zhuyechaihu Chinese thorowax root Radix Bupleuri Bupleurum marginatum Wall. ex DC. 15 
Huangqin Baikal skullcap root Scutellaria baicalensis Georgi Scutellaria baicalensis Georgi 15 
Dahuang Rhubarb Radix et Rhizoma Rhei Rheum palmatum L. 20 
Mangxiao Sodium sulfate Sodium Sulfate Na2SO4.10H2O 20 
Houpu Officinal magnolia bark Cortex Magnoliae Officinalis Magnolia officinalis Rehd. et Wils 15 
Zhishi Unripe bitter orange Fructus Aurantii Immaturus Citrus aurantium L. 15 
Zhizi Gardenia fruit Fructus Gardeniae Gardenia jasminoides Ellis 20 
Yinchen Capillary wormwood herb Herba Artemisiae Scopariae Artemisia capillaris Thunb 15 
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Germany) for determination of necrotic cell death pathway activation 
after staining with Hoechst 33342 (50 μg/ml) and propidium iodide (PI; 
1 μM). Necrotic cells were calculated as PI positive cells divided by 
Hoechst 33342 stained cells and multiplied by 100%. 
RAW264.7 mouse macrophages were cultured in Dulbecco's mod-
ified Eagle medium (DMEM) medium mixed with 10% fetal bovine 
serum in an incubator at 37 °C with saturated humidity and 5% CO2. 
Cell viability of RAW264.7 cells was assessed by Cell Counting Kit 8. 
Cells (approx. 8 × 103) were cultured overnight in a 96-well plate (100 
μl medium per well) and were incubated with compounds at different 
concentrations (12.5, 25, 50, 100, 200 μM, final concentration) for 
24 h. After changing the medium, Cell Counting Kit 8 solution (10 μl) 
was added into each well and incubated for 3 h away from light. 
Subsequently, the absorbance values of all the wells were measured by 
the BMG Labtech CLARIOstar Plate Reader (Ortenberg, Germany) at 
450 nm. Nitric oxide production was monitored by measuring the ni-
trite levels in culture medium as previously described (Joo et al., 2014). 
Briefly, RAW264.7 cells were pre-treated with active compounds at 
various concentrations (12.5, 25, 50 μM) for 24 h and subsequently 
stimulated with LPS (1 μg/ml) for another 24 h. The supernatant was 
collected to detect the nitrite levels which were calculated with re-
ference to a standard curve of sodium nitrite generated from known 
concentrations. Dose-effect curves of compounds on macrophage cell 
injury were analyzed using the median-effect method described 
previously (Chou, 2010). The combination index (CI) was calculated 
using ‘CompuSyn’ software (Cambridge, UK). Synergism (CI < 1), ad-
ditive effect (CI = 1), and antagonism (CI > 1) represent combination 
effects, respectively. The suppression rate of nitric oxide production is 
expressed as fraction affected (Fa). 
Statistical analysis 
Data were analyzed using analysis of variance (Ordinary one-way 
ANOVA) and Tukey's post-hoc test for multiple comparisons with Prism 
8.0 software (GraphPad Software Inc., La Jolla, CA, USA). Data are 
presented as mean ± S.E.M. A two-sided p < 0.05 was considered 
statistically significant. 
Results 
Analysis of CQCQD ingredients 
The phytochemical analysis based on UPLC-QTOF/MS made a pre-
liminary identification of 70 compounds from CQCQD by matching the 
molecular ions and fragment information using UNIFI 1.9.2 software. 
They belonged to flavonoids, iridoids, phenols, lignans, anthraquinones 
and corresponding glycosides, and those compounds with a high (> 
10,000) intensity were listed in Table S3. Of 70 compounds initially 
Fig. 1. Chemical ingredients analysis of CQCQD. (A) The three-dimensional UPLC-QTOF/MS of CQCQD. (B) Representative base peak intensity (BPI) chromatograms 
of CQCQD and standards. 
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identified in the CQCQD, 8 compounds (shanziside, geniposide, bai-
calin, chrysin, rhein, honokiol, magnolol and emodin) were listed as the 
representative active ingredients of monarch and minister drugs in 
CQCQD. They were confirmed by comparing retention time, molecular 
ions and fragmentions with corresponding standards in the mass spec-
trum (Fig. S1 and Table S5). The representative 3D UPLC-MS picture of 
CQCQD is displayed in Fig. 1A. The representative chromatograms of 
CQCQD and 8 standards are shown in Fig. 1B. 
Construction of TLR4/NLRP3 related sub-network and identification of 
targets-ingredients 
The flowchart of pharmacology network construction was shown in 
Fig. S2. A total of 27 con-targets were obtained, among them, 24 con- 
targets were further filtered out by PPI network with the minimum 
required interaction score of 0.7 (high confidence) (Fig. 2A). Further 
KEGG pathway enrichment analysis based on con-targets indicated 62% 
of all signaling pathways were associated with pro-inflammatory pro-
cess with AP, and a main “compounds-targets-pathways” network was 
constructed (Fig. S3). Of them, TLR, NF-κB and NLR are related to 
TLR4/NLRP3 pathways. In the TLR4/NLRP3 related sub-network, four 
cross-talk targets (TLR4, NF-κB1, RelA and TNF-α) are involved 
(Fig. 2B). PTGS2, TLR2 and IL-6 are targets related to NF-κB, TLR and 
NLR signaling pathway, respectively. Four active compounds (emodin, 
rhein, baicalin and chrysin) from CQCQD were predicted to have direct 
interactive function against cross-talking targets, while isosakuranetin- 
7-rutinosiede, hesperidin, geniposide, ( ± )-catechin had indirect effect 
(Fig. 2C). The chemical structure of four compounds are depicted in 
(Fig. 2D). 
Fig. 2. Pharmacological sub-network analysis- 
assisted screening of individual anti-in-
flammatory active ingredients from CQCQD. 
(A) The PPI network of 24 con-targets related 
to CQCQD major identified compounds and 
AP. (B) Four cross-talk targets constructed by 
Protein-Protein Interactions Network. (C) Sub- 
network of four active compounds (emodin, 
rhein, baicalin and chrysin) predicted to target 
NF-κB1, TNF-α, RelA and TLR4 that are asso-
ciated with NF-κB, TLR and NOD-like receptor 
(NLR) signaling pathways. Blue polygons de-
note ingredients from CQCQD, which could 
modulate targets in the 3 inflammatory path-
ways. Purple frames denote three signaling 
pathways involved. Red ovals denote four 
cross-talk targets. (D) Chemical structures of 
four compounds. (For interpretation of the re-
ferences to color in this figure legend, the 
reader is referred to the web version of this 
article.) 
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Fig. 3. Effects of CQCQD on severity indices of cerulein-induced AP in mice. Mice received 7 intraperitoneal injections of cerulein (CER; 50 μg/kg) at hourly interval 
to induce AP, while controls received normal saline at the same regimen. In the treatment groups, oral gavage of CQCQD (5, 10 and 15 g/kg) was implemented at 3, 5 
and 7 h from the first injection of cerulein. Animals were sacrificed at 12 h after the first CER/saline injection. (A) Representative H&E images of pancreatic sections 
(magnification 200 ×). (B) Pancreatic histopathology scores were exhibited as y axis. (C) Serum amylase. (D) Pancreatic trypsin activity. (E) Pancreatic myelo-
peroxidase (MPO) activity. (F) Representative H&E images of lung sections (magnification 200 ×). (G) Lung histopathology score. (H) Lung MPO activity. (I) Serum 
interlukin-6 (IL-6). Data are expressed as mean ± SEM of 6–8 animals per group. * p < 0.05 vs. control group, # p < 0.05 vs. CER group. In the histogram: gray = 
control, Red = CER, and Blue = CER with CQCQD. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this 
article.) 
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CQCQD attenuates pancreatic injury and systemic inflammation of CER-AP 
The representative hematoxylin and eosin (H&E)-stained pancreatic 
images are shown in Fig. 3A. Cerulein induced typical histopathological 
changes of AP manifesting as diffused edema, marked periductal and 
parenchymal neutrophil filtration (indicating inflammation) as well as 
scattered acinar cell necrosis that were reflected by increased histo-
pathological scores (Fig. 3B). These changes were associated with sig-
nificantly increased serum amylase (Fig. 3C), pancreatic trypsin activity 
(Fig. 3D), pancreatic MPO activity (Fig. 3E). The representative H&E 
lung images are shown in Fig. 3F. Cerulein injections caused sig-
nificantly increased alveolar septate thickening score (Fig. 3G), lung 
MPO activity (Fig. 3H) and serum IL-6 levels (Fig. 3I) compared with 
normal saline controls. Among 3 doses (5, 10, and 15 g/kg) tested, 
CQCQD at 10 g/kg significantly and consistently reduced all histo-
pathological and biochemical severity indices, while 5 and 15 g/kg 
were ineffective or only had partial protective effects (Fig. 3A-I). 
CQCQD at 20 g/kg had no significant impact on pancreatic histo-
pathology but increased pancreatic trypsin activity, lung histo-
pathology score, lung MPO activity and serum IL-6 levels (Fig. S4), 
indicating toxic effects caused by this dose. 
CQCQD down-regulates expression of TLR4/NLRP3-related mRNAs and 
proteins 
The results from semi-quantitative qRT-PCR are summarized in  
Fig. 4. Effects of CQCQD on pro-in-
flammatory signaling pathways of cer-
ulein-induced AP in mice. Mice received 7 
intraperitoneal injections of cerulein (CER; 
50 μg/kg) at hourly interval to induce AP, 
while controls received normal saline at 
the same regimen. In the treatment group, 
oral gavage of CQCQD (10 g/kg) was im-
plemented at 3, 5 and 7 h from the first 
injection of cerulein. Animals were sacri-
ficed at 12 h after the first CER/saline in-
jection. (A) RT-qPCR analysis for pro-in-
flammatory pathway mRNA expression in 
pancreatic tissue. (B) Representative 
Western blotting analysis results for pro-
tein expression in pancreatic tissue. (C) 
Representative immunohistochemistry 
images for pancreatic sections. Data are 
expressed as mean ± SEM of 3–6 samples 
per group. * p < 0.05 vs. control group, # p 
< 0.05 vs. CER group. In the histogram: 
gray = control, Red = CER, and Blue = 
CER with CQCQD. (For interpretation of 
the references to color in this figure le-
gend, the reader is referred to the web 
version of this article.) 
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Fig. 5. Effects of screened individual anti-inflammatory compound on necrotic cell death and TLR4/NLRP3 pro-inflammatory signaling pathway in acinar cells. 
Freshly isolated mouse pancreatic acinar cells received prior incubation with emodin (EM; 50 μM), rhein (RH; 25 μM), baicalin (BA; 25 μM) and chrysin (CH; 50 μM), 
or HEPES only for 30 min. Then cells were incubated with cholecystokinin (CCK; 500 nM) for 2 h or taurolithocholic acid 3-sulfate disodium salt (TLCS; 500 μM) for 
30 min, respectively. Cells were further stained with Hoechst 33342 and propidium iodide (PI; 1 μM) for determination of cell death by epifluorescence microscopy. 
Representative images and summary necrotic scores (%) for CQCQD active ingredients on (A) CCK- and (B) TLCS-induced necrotic cell death. (C) RT-qPCR analysis 
for pro-inflammatory pathway mRNA expression in acinar cells. Data are expressed as mean ± SEM from 3 or more independent experiments. * p < 0.05, ** p < 
0.01, and *** p < 0.001 vs. control group, # p < 0.05, ## p < 0.01 and ### p < 0.001 vs. CCK or TLCS group. In the histogram: gray = control, Red = CCK or TLCS, 
and Blue = CCK or TLCS with different compounds. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this 
article.) 
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Fig. 4A. The mRNA expression related to TLR4/NLRP3 pro-in-
flammatory signaling pathway (TLR4, MyD88, IKK, RelA, p50, NLRP3, 
caspase-1, IL-β and TNF-α) was significantly up-regulated in the CER- 
AP compared with normal saline controls. CQCQD at 10 g/kg sig-
nificantly reduced the mRNA expression of TLR4, MyD88, IKK, NLRP3 
and caspase-1 and with a tendency to reduce expression of other 
mRNAs. CQCQD also suppressed cerulein-induced up-regulation of 
protein expressions for p-p65, p-STAT3, caspase-1 (Western blot;  
Fig. 4B) and NLRP3 (immunohistochemistry; Fig. 4C). 
Validation of screened ingredients for necrotic cell death and TLR4/NLRP3- 
related pathways in acinar cells 
Next, we sought to validate the anti-inflammatory effects of the four 
(caption on next page) 
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compounds in both CCK- and TLCS-induced necrotic acinar cell death. 
The optimal concentration of corresponding isolated authentic com-
pounds was selected from various concentrations (12.5, 25 and 50 μM) 
tested with TLCS (500 μM) incubation (Fig. S5). All compounds at their 
respective optimal concentration significantly decreased CCK-induced 
acinar cell death with baicalin had the best protective effects followed 
by rhein, chrysin and emodin (Fig. 5A). All compounds significantly 
and equivalently reduced TLCS-induced acinar cell death (Fig. 5B). 
Individual compound had different inhibitory effects on the expression 
of TLR4, RelA, NLRP3 and TNF-α mRNAs that were up-regulated after 
TLCS stimulation: baicalin significantly reduced expression of TLR4 
mRNA; baicalin and chrysin significantly reduced expression of RelA 
mRNA; emodin and baicalin significantly reduced expression of NLRP3 
mRNA; emodin and chrysin significantly reduced expression of TNF-α 
mRNA (Fig. 5C). While in the presence of LPS, only emodin sig-
nificantly decreased TLCS-induced over-expression of TLR4 and NLRP3 
mRNAs (Fig. S6). 
Validation of screened ingredients for cell viability and TLR4/NLRP3- 
related pathways in RAW 264.7 macrophages 
The cell viability showed that the four compounds had no cyto-
toxicity to RAW264.7 cells up to 50 μM (Fig. 6A). Appropriate timing 
for LPS stimulation and compound pre-incubation was assessed first 
(Fig. S7). Then a strategy of 24 h pre-incubation of individual com-
pounds followed by another 24 h LPS co-incubation was employed. Cell 
injury of RAW264.7 cells was assessed by measuring nitric oxide pro-
duction shown in histogram (Fig. 6B). Compared with culture medium 
controls, LPS caused dramatic nitric oxide release that was suppressed 
by emodin in a dose-dependent manner and with the maximal effect 
obtained at 50 μM. While both rhein and chrysin significantly reduced 
nitric oxide production at all concentrations tested, the same dose-de-
pendent effect was not observed. Baicalin had no significant effect on 
LPS-induced nitric oxide production. 
The effects of emodin, rhein and chrysin on the mRNA expression 
profile of the TLR4/NLRP3 pathways are shown in (Fig. 6C). LPS sti-
mulation significantly up-regulated expression of TLR4, NLRP3, RelA 
and TNF-α mRNAs. Both emodin and chrysin significantly reduced 
expression of TLR4, NLRP3 and TNF-α mRNAs. Rhein significantly re-
duced expression of NLRP3 mRNA but was not effective for other 
mRNAs. None of the three compounds significantly altered expression 
of RelA mRNA. Dose-effect curves of individual compound and com-
bination of them were plotted for nitric oxide suppression activity in 
RAW264.7 cells (Fig. 6D). A synergistic suppression effect was observed 
on LPS-induced nitric oxide production with Fa values (Fig. 6D). 
Combination showed synergistic effects both at low dose (Fa < 0.3) 
and high dose (Fa > 0.8). However, an antagonistic interaction was 
observed with CI values ranging from 1.16 to1.55. Emodin, rhein and 
chrysin respectively inhibited the expression of MyD88 and NLRP3 
proteins (Fig. 6E). Further, their combination had even stronger in-
hibitory effects compared with individual compounds alone, high-
lighting a synergistic effect. 
Discussion 
For the first time, the anti-inflammatory effects of CQCQD against 
AP were studied using the “multiple ingredients-targets-pathways” 
approach through a network pharmacology analysis. The main findings 
from this study were: (1) A pharmacological sub-network of “3 in-
flammatory pathways-4 cross talk targets-4 compounds” was built. Four 
active compounds: emodin, rhein, baicalin and chrysin from CQCQD 
were identified. These molecules act on the TLR4/NF-κB/NLRP3-re-
lated proteins, TLR4, RelA, NF-κB and TNF-α; (2) CQCQD significantly 
reduced the severity of CER-AP and this was associated with suppres-
sion of TLR4/NLRP3 inflammasome-mediated pro-inflammatory sig-
naling pathway-related mRNAs and proteins; (3) In vitro experiments 
validated the protective effects of these four compounds on acinar cells 
via inhibition of TLR4/NLRP3 pathways. While baicalin was the most 
effective in preventing pancreatic acinar cell injury, the other three 
compounds (emodin, rhein and chrysin) reduced LPS-induced cell 
death and TLR4/NLRP3 pathway activation in macrophages. The 
combination of these compounds representing CQCQD bioactive in-
gredients produced a synergistic protective effect when compared to 
individual compound acting on their own. These data support the po-
tential for developing a range of CQCQD-based pharmacological treat-
ments for AP. 
Severe AP is characterized by the early development of persistent 
the systemic inflammatory response syndrome, followed by irreversible 
organ failure. It is often complicated by pancreatic necrosis, sepsis, and 
death (Guo et al., 2014; Schepers et al., 2019; Shi et al., 2020). Cor-
respondingly, according to TCM theory, the early stage of severe AP is 
defined as “Yangming viscera syndrome”, manifested as abdominal 
distention, fullness and pain. DCQD is a classical prescription for the 
treatment of this syndrome and has been shown to improve gut dys-
function and reduce severity of AP in animal models (Lu et al., 2017) 
and human patients (Wan et al., 2012). This is proposed to be largely 
due to its anti-inflammatory and anti-oxidative stress effects. CQCQD is 
derived from DCQD with the original intention to enhance its ther-
apeutic efficacy against biliary AP. The addition of Bupleurum margin-
atum Wall. ex DC., Scutellaria baicalensis Georgi, Gardenia jasminoides 
Ellis and Artemisia capillaris Thunb in CQCQD was designed to increase 
the anti-inflammatory effects of DCQD (Jang et al., 2015; Jung et al., 
2008; Zhao et al., 2015). These anti-inflammatory effects of CQCQD 
observed in this current study were consistent with previous reports 
showing that in rats CQCQD significantly reduced lung and intestinal 
injuries in sodium taurocholate-induced experimental AP (NaT-AP) 
(Wu et al., 2016) and L-arginine-induced AP (Zhang et al., 2017) re-
spectively. In recent years, the incidence of hypertriglyceridemia-as-
sociated AP has rapidly increased in China (Ding et al., 2019;  
Mukherjee et al., 2019; Shi et al., 2020; Zhang et al., 2019c), attributing 
to a high prevalence of central obesity (Zhang et al., 2019a) or meta-
bolic syndrome (Ding et al., 2016). In addition, hypertriglyceridemia- 
associated AP is often more severe when compared with other etiolo-
gies due to its more pronounced pro-inflammatory effects and worse 
clinical outcomes (Ding et al., 2019; Zhang et al., 2019c). Recent stu-
dies have demonstrated that components in CQCQD such as 
Fig. 6. Effects of screened compounds for cell viability, cell injury and TLR4/NLRP3 pro-inflammatory signaling pathway in RAW 264.7 cells. RAW 264.7 mac-
rophage cells received prior incubation with emodin (EM; 50 μM), rhein (RH; 25 μM), baicalin (BA; 25 μM) and chrysin (CH; 50 μM), or culture medium only for 24 h 
followed by co-incubation with lipopolysaccharide (LPS; 1 μg/ml) for another 24 h. (A) Effects of four compounds representing screened ingredients on cell viability 
(Cell Counting Kit 8). Solid hexagon (EM), solid rhombus (RH), solid round (BA), square (CH) (B) Dose effects of each compound on nitric oxide production after LPS 
stimulation. Three concentrations (12.5, 25 and 50 μM) were tested for each compound. (C) Effects of each compound at their respective optimal concentration on 
expression of TLR4, NLRP3, RelA and TNF-α mRNAs after LPS stimulation. (D) Does-effect curve of EM, RH and CH at respective optimal concentration and their 
combination index (CI) values were plotted according to suppression rate of nitric oxide production (Fa). In dose-effect curve, round (EM), square (RH), regular 
triangle (CH), inverted triangle (COM). In CI curve, dotted line is the reference line, where CI value equals to 1; solidline (Blue) represents CI values at different Fa 
values. (E) Effects of optimal concentration of EM, RH, CH and their combination ‘COM’ (EM:RH:CH = 4:1:1) on expression of NLRP3 and MyD88 proteins (Western 
blot). Data are expressed as mean ± SEM from 3 or more independent experiments. * p < 0.05, ** p < 0.01, and *** p <0.001 vs. control group, # p < 0.05, ## p < 
0.01 and ### p < 0.001 vs. LPS group. In the histogram: gray = control, Red = LPS, and Blue = LPS with different compounds. (For interpretation of the references 
to color in this figure legend, the reader is referred to the web version of thisarticle.) 
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Gardenia jasminoides Ellis (Ahmed et al., 2018) can antagonize pan-
creatic triglyceride lipase, a key factor for lipolysis and lipotoxicity 
(de Oliveira et al., 2020) . 
TLR4/NLRP3 pro-inflammatory signaling pathways play a critical 
role for primary pancreatic toxin- and DAMP-induced pancreatic injury 
and systemic inflammation (Chen et al., 2014; Kang et al., 2014a;  
Szatmary et al., 2018). However, the specified and precise active in-
gredients of CQCQD and their synergistic protective effect on inhibiting 
key pro-inflammatory pathways (i.e. TLR4/NLRP3) have remained 
elusive. Through RT-qPCR, Western blot and immunohistochemistry, 
we confirmed that CQCQD and its active ingredients alleviated severity 
of AP at least in part through suppressing TLR4/NLRP3 related path-
ways. Natural TLR4 antagonists were mainly obtained from gram-ne-
gative bacteria, cyanobacteria, or from plants. Curcumin, sulforaphane, 
iberin, xanthohumol, celastrol, berberine, atractylenolide I and zhan-
kuic acid A have been described as natural molecules for TLR4 antag-
onism (Molteni et al., 2018). A study by Li et al., (2009) showed that 
combination of emodin and baicalin suppressed severity and reduced 
TLR4 expression in pancreas and lung in NaT-AP in rats. Recently, a 
mechanistic study revealed that about 34 phytochemicals could alter 
the NLRP3 inflammasome activity in acute and chronic inflammatory 
diseases (Jahan et al., 2017). Among them, emodin and curcumin were 
found to be involved in modulation of NLRP3 activation in septic shock 
models. One recent study indicated that emodin could attenuate the 
severity of AP via the pancreatic P2X7/NLRP3 signaling pathway in 
NaTC-AP in rats (Zhang et al., 2019b). Furthermore, some natural 
herbal medicines can neutralize the toxicity of extracellular histones 
(Isobe et al., 2016). In according with this, our team has recently found 
some active ingredients (e.g. baicalin) from CQCQD demonstrated high 
binding affinity to histone H3, implying a more potent detoxifying 
capability of CQCQD. This research topic, therefore, warrants further 
in-depth investigation to establish a potential pathway for the discovery 
of novel drugs. 
Pharmacological network analysis and mapping are essential tools 
for exploring the dynamic ingredient-target-pathway relationship be-
tween TCM herbal formulae and diseases (Sun et al., 2020). Using these 
tools, the team identified correlations between the bioactive ingredients 
of CQCQD and AP targets using established disease and target data-
bases. In addition, KEGG was used to search for 21 known AP-related 
pathways, including MAPK, PI3K-Akt, IL-17, TNF, TLR, NF-κB, NLR, 
sphingolipid, adipocytokine, RIG-I-like receptor, T cell receptor, P53 
and etc.Through analysis, we found that inflammatory pathways ac-
counted for 62% of all mechanisms involved in AP, and TLR4/NF-κB/ 
NLRP3 cassette plays a central role in all inflammatory pathways. 
Therefore, we subsequently selected four common targets related to 
TLR4/NLRP3 inflammasome-mediated pro-inflammatory pathways and 
constructed a pharmacological sub-network for CQCQD. The sub-net-
work revealed that RelA, TLR4, NF-κB1 and TNF-α were crucial cross- 
talk targets for TLR, NF-κB and NLR signaling pathways. Further sub- 
network analysis enabled the team to filter out four active compounds 
of CQCQD (emodin, rhein, baicalin and chrysin) that directly act on 
these targets by using relevant TCM databases. 
Among these four compounds, emodin and rhein were from Rheum 
palmatum L., the principle drug in both DCQD and CQCQD. Baicalin 
and chrysin were from Scutellaria baicalensis Georgi. In this study, no 
protective effect of baicalin on reducing cell injury was observed in 
cultured macrophages. Baicalin was the main metabolite of baicalein 
after its administration in animals and human (Tian et al., 2012). 
However, there is no clear evidence showing this conversion occurred 
in cell culture systems (Chen et al., 2001), thus it is difficult to rule out 
the possibility that baicalein may actually be responsible for the pro-
tective effects. While various studies have investigated the role of 
emodin, rhein and baicalin or its aglycone baicalein in experimental 
AP, the role of chrysin has not been appraised in AP settings yet. 
Chrysin (5,7-dihydroxy-2-phenyl-4H-chromen-4-one) is a natural fla-
vone found in several plants, mushroom, and honeycomb. It has been 
reported to be protective in inflammatory diseases such as sclerosis and 
diabetes (Ramirez-Espinosa et al., 2017). Here we have now shown that 
chrysin had consistent effects in reducing cell death in pancreatic acinar 
cells and macrophages by down-regulating the expression of TLR4/ 
NLRP3 pathways related mRNAs and proteins. 
Importantly in this study, in order to evaluate the synergistic effects 
of these compounds that representing active ingredients in CQCQD, all 
three compounds were combined at their relative ratios according to 
the HPLC results. It was observed that their synergistic protective effect 
was positively correlated with an increase in dosage until the maximum 
safety dose was reached. This finding highlighted the existence of a 
potent dose-effect relationship, but also the need for robust quality 
control of raw TCM herbal ingredients and the extraction process. 
Unlike their synthetic counterparts, most Chinese herbal medicines 
have not been pharmaceutically evaluated to define their pharmaco-
dynamic, pharmacokinetic properties as well as key parameters such as 
optimal, effective, and toxic dosing. Consequently, unduly increased 
doses or prolong administrations of TCM herbal formula can cause 
adverse reactions (Cheng and Leung, 2012). In this study, the safety 
parameters and dose-efficacy relationship between CQCQD and severity 
scale in a mouse CER-AP model were also assessed for the first time. 
Using the human-mice dose equivalent coefficient, we determined that 
the clinically-proven optimal human dose in mice is 5.75 g/kg. Using 
this as a reference point, a four-dose regimen ranging from low to high 
was derived (5, 10, 15, and 20 g/kg). The results suggest CQCQD was 
most effective in reducing systematic inflammatory parameters in 
pancreas and lung at 10 g/kg (approximately twice of the reference 
dosage). The other CQCQD lower dosages were not as effective as 10 g/ 
kg, and the 20 g/kg regimen was associated with increased lung injury 
and elevated serum IL-6 levels, indicating potential toxic effects. 
There are several limitations to this study. As we focused on TLR4/ 
NLRP3 related pathways, we may have underestimated the impact of 
other pro-inflammatory or signaling pathways such as the anti-oxidant 
property also possess by CQCQD. Indeed, the CQCQD has a wide range 
of active ingredients including flavonoids, anthraquinones, iridoids, 
phenols, lignans, and corresponding glycosides, most of which have 
been reported to be capable of reducing AP severity via antagonizing 
reactive oxygen species by activating nuclear factor erythroid-2-related 
factor 2/antioxidant response element, an intrinsic antioxidative stress 
pathway (Shapiro et al., 2007). Therefore, much more work is needed 
to understand the complex mechanisms and full range of presumed 
therapeutic targets between AP and CQCQD. 
In conclusion, the present study demonstrated that CQCQD could 
alleviate the severity of experimental AP at least in part via inhibition of 
TLR4 and the NLRP3 inflammasome. Pharmacological network analysis 
and experimental validation identified that four CQCQD bioactive 
compounds (emodin, rhein, baicalin and chrysin) are responsible for 
these effects. Emodin, rhein and chrysin were also found to work sy-
nergistically to mitigate cell injury and suppress TLR4/NLRP3 related 
pathways in cultured macrophages. 
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